Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study—Report 9
Investigative Ophthalmology & Visual Science · 27.06.2024 · 65 (6) · 38
DOI: 10.1167/iovs.65.6.38 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 27.06.2024. Verfasst von Patrícia Barreto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Disease Progression, Macular Degeneration. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
To assess the association of age-related macular degeneration (AMD) progression and statins, connected with AMD genetic risk, and if there is an interplay between statins and genetics.
Methods
In this analysis, 682 subjects made two visits (6.5-year follow-up) of the Coimbra Eye Study. Subjects who started taking statins at any time point between the two visits were considered. Progressors were defined as not having AMD at baseline and having any AMD at follow-up. Genetic risk scores (GRSs) were calculated individually with 52 independent variants associated with AMD. Time to progression was estimated using unadjusted Kaplan-Meier curves. An extended Cox model was used for the association between statins and GRS with the risk for AMD progression. Multiplicative and additive interactions were assessed.
Results
Median survival time was 7.50 years for subjects not taking statins and 7.62 for subjects taking statins (P < 0.001). Statin intake reduced the risk for progression to AMD in 48%, adjusting for age, sex, body mass index, smoking, and diabetes (model 1) and GRS (model 2). The combined effects of not taking statins and having high GRS increased the progression risk fourfold compared to taking statins and having low GRS (hazard ratio [HR] = 4.25; 95% confidence interval [CI], 1.62-11.16; P = 0.003). For subjects not taking statins, an increased risk of progression was found for those subjects with high GRS compared to subjects with low GRS (HR = 1.80; 95% CI, 1.13-2.85; P = 0.013). No statistically significant multiplicative or additive interactions were found.
Conclusions
Statins seem to be protective against AMD progression, and genetics may play a role in treatment response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal.
- Faculty of Medicine, Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, Coimbra, Portugal.
- Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.
- Ophthalmology Department, Coimbra Hospital and University Center (CHUC), Coimbra, Portugal.
- Faculty of Medicine, Clinical Academic Center of Coimbra (CACC), University of Coimbra, Portugal.
- Department of Mathematics, University of Aveiro, Aveiro, Portugal.
Zitieren
APA
Barreto, P., Farinha, C., Coimbra, R., Cachulo, M. L., Melo, J. B., Lechanteur, Y., Hoyng, C. B., Cunha-Vaz, J., & Silva, R. (2024). Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study—Report 9. Investigative Ophthalmology & Visual Science, 65(6), 38. https://doi.org/10.1167/iovs.65.6.38
Vancouver
Barreto P, Farinha C, Coimbra R, Cachulo ML, Melo JB, Lechanteur Y, et al. Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study—Report 9. Investigative Ophthalmology & Visual Science. 2024;65(6):38. doi:10.1167/iovs.65.6.38
BibTeX
@article{Barreto2024,
author = {Barreto, Patrícia and Farinha, Cláudia and Coimbra, Rita and Cachulo, Maria Luz and Melo, Joana Barbosa and Lechanteur, Yara and Hoyng, Carel B and Cunha-Vaz, José and Silva, Rufino},
title = {Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study—Report 9},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
volume = {65},
number = {6},
pages = {38},
doi = {10.1167/iovs.65.6.38}
}
EUVIMED